Sonsoles Morcillo1,2, Manuel Macías-González3,4, Francisco J Tinahones3,4. 1. Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Clínico Virgen de la Victoria, Málaga, Spain. sonsoles75@gmail.com. 2. CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Málaga, Spain. sonsoles75@gmail.com. 3. Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Clínico Virgen de la Victoria, Málaga, Spain. 4. CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Málaga, Spain.
Abstract
PURPOSE OF REVIEW: Metabolic and bariatric surgery (MBS) is considered to be the most effective treatment for obesity. Not only due to the significant weight reduction but also because of the many health benefits associated with it. In the last 5 years, several studies have suggested that epigenetic modifications could be involved in the mechanisms underlying the response to bariatric surgery. In this review, we will compile the different studies (2012-2017) concerning the effect of this surgical procedure on DNA methylation patterns (the most studied epigenetic marker) and its association with metabolic improvement. This is an emerging area, and currently, there are not many studies in the literature. The aim is to show what has been done so far and what the future direction in this emerging area might be. RECENT FINDINGS: Recent findings have shown how metabolic and bariatric surgery modifies the DNA methylation profile of the specific genes associated with the pathophysiology of the disease. The studies were performed in morbidly obese subjects, mainly in women, with the aim of reducing weight and improving the obesity-associated comorbidities. DNA methylation has been measured both in specific tissue and in peripheral blood samples. In general, studies about site-specific DNA methylation have shown a change in the methylation profile after surgery, whereas the studies analyzing global DNA methylation are not so conclusive. Summing up, metabolic and bariatric surgery can modify the DNA methylation profile of different genes and contributes to the metabolic health benefits that are often seen after metabolic and bariatric surgery. Although there are still many issues to be resolved, the capacity to revert the DNA methylation profile of specific sites opens a window for searching for target markers to treat obesity-related comorbidities.
PURPOSE OF REVIEW: Metabolic and bariatric surgery (MBS) is considered to be the most effective treatment for obesity. Not only due to the significant weight reduction but also because of the many health benefits associated with it. In the last 5 years, several studies have suggested that epigenetic modifications could be involved in the mechanisms underlying the response to bariatric surgery. In this review, we will compile the different studies (2012-2017) concerning the effect of this surgical procedure on DNA methylation patterns (the most studied epigenetic marker) and its association with metabolic improvement. This is an emerging area, and currently, there are not many studies in the literature. The aim is to show what has been done so far and what the future direction in this emerging area might be. RECENT FINDINGS: Recent findings have shown how metabolic and bariatric surgery modifies the DNA methylation profile of the specific genes associated with the pathophysiology of the disease. The studies were performed in morbidly obese subjects, mainly in women, with the aim of reducing weight and improving the obesity-associated comorbidities. DNA methylation has been measured both in specific tissue and in peripheral blood samples. In general, studies about site-specific DNA methylation have shown a change in the methylation profile after surgery, whereas the studies analyzing global DNA methylation are not so conclusive. Summing up, metabolic and bariatric surgery can modify the DNA methylation profile of different genes and contributes to the metabolic health benefits that are often seen after metabolic and bariatric surgery. Although there are still many issues to be resolved, the capacity to revert the DNA methylation profile of specific sites opens a window for searching for target markers to treat obesity-related comorbidities.
Entities:
Keywords:
Bariatric surgery; DNA methylation; Epigenetic; Metabolic improvement; Weight reduction
Authors: Derek K Hagman; Ilona Larson; Jessica N Kuzma; Gail Cromer; Karen Makar; Katya B Rubinow; Karen E Foster-Schubert; Brian van Yserloo; Peter S Billing; Robert W Landerholm; Matthew Crouthamel; David R Flum; David E Cummings; Mario Kratz Journal: Metabolism Date: 2017-02-02 Impact factor: 8.694
Authors: Henry Buchwald; Rhonda Estok; Kyle Fahrbach; Deirdre Banel; Michael D Jensen; Walter J Pories; John P Bantle; Isabella Sledge Journal: Am J Med Date: 2009-03 Impact factor: 4.965
Authors: Markus Ahrens; Ole Ammerpohl; Witigo von Schönfels; Julia Kolarova; Susanne Bens; Timo Itzel; Andreas Teufel; Alexander Herrmann; Mario Brosch; Holger Hinrichsen; Wiebke Erhart; Jan Egberts; Bence Sipos; Stefan Schreiber; Robert Häsler; Felix Stickel; Thomas Becker; Michael Krawczak; Christoph Röcken; Reiner Siebert; Clemens Schafmayer; Jochen Hampe Journal: Cell Metab Date: 2013-08-06 Impact factor: 27.287
Authors: Ida Donkin; Soetkin Versteyhe; Lars R Ingerslev; Kui Qian; Mie Mechta; Loa Nordkap; Brynjulf Mortensen; Emil Vincent R Appel; Niels Jørgensen; Viggo B Kristiansen; Torben Hansen; Christopher T Workman; Juleen R Zierath; Romain Barrès Journal: Cell Metab Date: 2015-12-06 Impact factor: 27.287
Authors: Miles C Benton; Alice Johnstone; David Eccles; Brennan Harmon; Mark T Hayes; Rod A Lea; Lyn Griffiths; Eric P Hoffman; Richard S Stubbs; Donia Macartney-Coxson Journal: Genome Biol Date: 2015-01-22 Impact factor: 13.583
Authors: Emil K Nilsson; Barbara Ernst; Sarah Voisin; Markus Sällman Almén; Christian Benedict; Jessica Mwinyi; Robert Fredriksson; Bernd Schultes; Helgi B Schiöth Journal: PLoS One Date: 2015-02-24 Impact factor: 3.240
Authors: Valentina Ivezaj; Stephen C Benoit; Jon Davis; Scott Engel; Celia Lloret-Linares; James E Mitchell; M Yanina Pepino; Ann M Rogers; Kristine Steffen; Stephanie Sogg Journal: Curr Psychiatry Rep Date: 2019-08-13 Impact factor: 5.285
Authors: C F Nicoletti; M A S Pinhel; A Diaz-Lagares; F F Casanueva; A Jácome; V C Pinhanelli; B A P de Oliveira; A B Crujeiras; C B Nonino Journal: BMC Med Genomics Date: 2019-05-27 Impact factor: 3.063